SCHEMBL3369734

SCHEMBL3369734

CC(C)N1CCC(NC(=O)c2nc3c(C(=O)NCCO)cccc3n2CC(=O)Nc2ccc(Cl)cn2)CC1

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.63
F2 P00734 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1381138 0.91 F10 (0.67) F10F2
SCHEMBL3370041 0.90 F10 (0.65) F10F2
SCHEMBL1380612 0.89 F10 (0.60) F10F2
SCHEMBL1377876 0.88 F10 (0.67) F10F2
SCHEMBL1382572 0.88 F10 (0.61) F10F2
SCHEMBL1381668 0.87 F10 (0.62) F10F2
SCHEMBL1378573 0.87 F10 (0.62) F10F2
SCHEMBL1383452 0.87 F10 (0.63) F10F2
SCHEMBL3372698 0.86 F10 (0.61) F10F2
SCHEMBL6017061 0.86 F10 (0.61) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636216-B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS SANOFI AVENTIS DEUTSCHLAND (DE) 2010-07-21 EP claimed
EP-1479676-A1 Benzimidazole-derivatives as factor xa inhibitors Aventis Pharma Deutschland GmbH (DE) 2004-11-24 EP claimed
EP-1636216-B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS SANOFI AVENTIS DEUTSCHLAND (DE) 2010-07-21 EP disclosed
EP-1636216-A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS Sanofi-Aventis Deutschland GmbH (DE) 2006-03-22 EP disclosed
WO-2004101553-A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2004-11-25 WO disclosed